Materialise Expands Cardiovascular Capabilities With AI Software

Materialise, a global leader in 3D printing software and services, has acquired FEops, a Belgian company specializing in AI (artificial intelligence)-driven simulation technology. FEops’ solution enables improved capacity, efficiency and clinical outcomes for structural cardiac interventions. Although the amount of the transaction was not disclosed, this acquisition will enable Materialise to expand its cardiovascular solutions by integrating predictive simulation capabilities, promoting personalized treatment for patients with heart disease.

The use of 3D technologies is revolutionizing healthcare by enabling mass customization of treatment plans and interventions, tailored to the unique anatomy of each patient. In particular, structural heart disease, such as valvular heart disease, is a significant medical and economic challenge, being one of the leading causes of cardiovascular mortality worldwide. Currently, 47 million people suffer from valvular heart disease, and by 2030 the costs associated with these problems are expected to reach $70 billion per year globally. By combining simulation software, AI and 3D planning technologies, Materialise now expects to expand its capabilities to address this growing challenge.

Materialise notes that this AI-driven simulation software will help improve cardiovascular outcomes

Materialise Turns to AI

One of the activities carried out by Materialise is the mass customization of healthcare by creating 3D virtual models based on medical images for pre-procedure planning. Now, the integration of FEops technology with Mimics Planner, Materialise’s software, will offer a comprehensive solution for anatomy-based 3D planning and AI simulation. Brigitte de Vet, CEO of Materialise, highlighted the importance of this union, noting, “By integrating FEops’ advanced predictive simulation technology with our Mimics Planner, we are expanding our cardiovascular solutions to provide clinicians with comprehensive insights into patient anatomy. This integration will not only enhance the accuracy and efficiency of structural heart interventions but also improve clinical outcomes and patient safety.”